Headlines

Motley Rice is proud to announce that several of its attorneys, who represent clients across an array of practice areas, have been selected for inclusion in the 2014 South Carolina Super Lawyers and Rising Stars lists and 2014 Washington, D.C. Super Lawyers list.

Four of Motley Rice’s members are included in the 2014 edition of Benchmark Plaintiff’s inaugural Top 150 Women in Litigation list.

The 2014 editions of Benchmark Plaintiff and Benchmark Litigation were released and include multiple mentions of Motley Rice attorneys.

Motley Rice was a proud sponsor of the 10th annual International Asbestos Awareness Conference, presented by the Asbestos Disease Awareness Organization (ADAO).

In February and March of 2014, GM recalled 2.6 million Chevrolet Cobalts and HHRs, Saturn Ions and Skys, and Pontiac G5s and Solstices because of defective ignition switches. GM admitted that “a condition with the ignition switch…may allow the key to unintentionally move or switch to the ‘accessory’ or ‘off’ position, turning off the engine and most of the electrical components on the vehicle,” including causing air bag failure in the event of a crash.

On Monday, April 7, a federal court jury in Louisiana decided that Takeda Pharmaceuticals and Eli Lilly hid the risks of bladder cancer from the diabetes drug, Actos.

Motley Rice is reviewing potential claims involving the proposed acquisition of SWS Group, Inc. (“SWS” or the “Company”) (NYSE: SWS) by Hilltop Holdings Inc. (“Hilltop”) (NYSE: HTH).

Since the Deepwater Horizon disaster four years ago this month, BP has been “April Fooling” us that they are actually going to take responsibility for their actions.

On March 5, 2014, the U.S. Supreme Court heard oral arguments in the appeal of Halliburton Co. v. Erica P. John Fund, Inc.. The Court’s forthcoming opinion, expected by June 2014, will decide the continuing vitality of the fraud-on-the-market presumption, one of the legal underpinnings of modern securities-fraud class actions.

Motley Rice is investigating possible anti-competitive behavior that allegedly caused financial injury to investors who, from 2004 to now, held or traded gold and gold derivatives that were priced based on the London gold fix or who held or traded COMEX gold futures or options.